Calcium Deregulation and Mitochondrial Bioenergetics in GDAP1-Related CMT Disease
- PMID: 30669311
- PMCID: PMC6359725
- DOI: 10.3390/ijms20020403
Calcium Deregulation and Mitochondrial Bioenergetics in GDAP1-Related CMT Disease
Abstract
The pathology of Charcot-Marie-Tooth (CMT), a disease arising from mutations in different genes, has been associated with an impairment of mitochondrial dynamics and axonal biology of mitochondria. Mutations in ganglioside-induced differentiation-associated protein 1 (GDAP1) cause several forms of CMT neuropathy, but the pathogenic mechanisms involved remain unclear. GDAP1 is an outer mitochondrial membrane protein highly expressed in neurons. It has been proposed to play a role in different aspects of mitochondrial physiology, including mitochondrial dynamics, oxidative stress processes, and mitochondrial transport along the axons. Disruption of the mitochondrial network in a neuroblastoma model of GDAP1-related CMT has been shown to decrease Ca2+ entry through the store-operated calcium entry (SOCE), which caused a failure in stimulation of mitochondrial respiration. In this review, we summarize the different functions proposed for GDAP1 and focus on the consequences for Ca2+ homeostasis and mitochondrial energy production linked to CMT disease caused by different GDAP1 mutations.
Keywords: GDAP1; calcium regulated cell respiration; mitochondrial location; recessive mutations; store operated calcium entry.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Baxter R.V., Ben Othmane K., Rochelle J.M., Stajich J.E., Hulette C., Dew-Knight S., Hentati F., Ben Hamida M., Bel S., Stenger J.E., et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat. Genet. 2002;30:21–22. doi: 10.1038/ng796. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- SAF2015-66625-R/Ministerio de Economía, Industria y Competitividad, Gobierno de España
- SAF2014-56929R/Ministerio de Economía, Industria y Competitividad, Gobierno de España
- SAF2017-82560-R/Ministerio de Economía, Industria y Competitividad, Gobierno de España
- IR11/TREAT-CMT/Instituto de Salud Carlos III
- 2015 FEDER/S-21/Generalitat de Catalunya
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
